Another quarter of double-digit growth; full-year targets exceeded
25/02/21 -"Benefitting from sustained demand for COVID-19 testing solutions, bioMerieux reported another quarter of double-digit growth in Q4 20. Interestingly, the FY20 targets were exceeded, both on the sales ..."
Pages
64
Language
English
Published on
25/02/21
You may also be interested by these reports :
19/04/24
Orpea’s 2023 key underlying results met the guidance. The management noted the inflationary staff costs and yet-to-restore occupancy which weighed ...
18/04/24
While the near-term performance is expected to be impacted by various challenges, there are still some promising takeaways from our recent discussion ...
16/04/24
Drägerwerk reported softer-than-expected Q1 24 numbers, with sales declining by 2.6%. As expected, growth in the safety segment partly offset the ...
15/04/24
The FY23 reported EPS came in ahead of our expectations, as the firm more than offset the H2 23 wage inflation with very strong profit margin ...